Lähetä linkki
RSS
google +
Tulostusversio

Uutisia (Ikääntyminen)

This section on health in the EU has been created as a trustworthy gateway to a wide range of information and data on health-related issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), plus EU candidate countries; by international organisations; and by pan-European non-governmental organisations in the area of public health.

Wearables & apps for Parkinson's disease: why big data & big names may not be small enough    epda.eu.com

While headlines recently surged over big organisations such as Intel, Apple, and the Michael J. Fox Foundation partnering to launch pilot studies on wearables, mobile apps, and big data for Parkinson[...]

Zambon launches Xadago (safinamide) for patients with mid- to late-stage Parkinson's disease in Germany    epda.eu.com

Germany is the first country in which Xadago is available as an add-on to levodopa alone and in combination with other PD medications.[...]

Amarantus receives notice of allowance for U.S. patent application for treatment of Parkinson's    epda.eu.com

Patent issuance will provide IP protection for lead product candidate eltoprazine for treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID)[...]

2015 Ageing Report warns of growing cost of ageing population    epha.org

On 12 May the European Commission published The 2015 Ageing Report, which presents economic and budgetary projections for the 28 EU member states for the period 2013-2060. Though the total population[...]

Success Stories - Movement sensor device improves life quality for Parkinson's patients    europa.eu

A small sensor, headphones and a mobile phone - the elements of a prototype kit that is giving hope of relief for sufferers of Parkinson's disease. The European-backed research project being spearhea[...]

Vitamin D from different sources is inversely associated with Parkinson disease    epda.eu.com

Study data confirm the association between vitamin D deficiency and PD, and for the first time demonstrate an inverse association of 25(OH)D2 with PD. Given that 25(OH)D2 concentration is independent[...]

The Michael J. Fox Foundation and Prothena partner to accelerate discovery of novel biomarkers for Parkinson's disease    epda.eu.com

The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Prothena Corporation plc, a late-stage clinical biotechnology company focused on the discovery, development and commercialisation of [...]

Trust your gut: E. coli may hold one of the keys to treating Parkinson's    epda.eu.com

E. coli usually brings to mind food poisoning and beach closures, but researchers recently discovered a protein in E. coli that inhibits the accumulation of potentially toxic amyloids - a hallmark of[...]

UNC team uses cellular bubbles to deliver Parkinson's meds directly to brain    epda.eu.com

Researchers at the University of North Carolina at Chapel Hill have used exosomes tiny bubbles of protein and fat produced naturally by cells to bypass the body's defences and deliver a potent biopha[...]

Programme - Conference 'Innovative Financing Opportunities for Active & Healthy Ageing' (3 June 2015)    europa.eu

European Commission - Brussels, 3 June 2015   About the Conference [...]

Parkinson's Life a new 'webzine' for the international Parkinson's community now live!    epda.eu.com

A new and innovative magazine-style website has been launched to inspire and inform the international Parkinson's community.[...]

Boston Scientific announces strategic collaboration with Brainlab AG    epda.eu.com

Boston Scientific Corporation (NYSE: BSX) announces a collaboration with Brainlab AG, a leading software-driven medical technology company that helps improve patient treatment planning and surgical n[...]

Diary app helps track disease progress in Parkinson's patients    epda.eu.com

An iPad app diary may help track Parkinson's disease symptoms and have implications for clinical care, an ongoing study indicates.[...]

Critical Path Institute secures regulatory support for Parkinson's and Alzheimer's disease biomarkers    epda.eu.com

Critical Path Institute (C-Path) announced that the U.S. Food and Drug Administration (FDA) has issued three Letters of Support to C-Path's Coalition Against Major Diseases (CAMD) consortium for the [...]

Gait and upper limb variability in Parkinson's disease patients with and without freezing of gait    epda.eu.com

Findings demonstrate that: (1) freezers have a higher spatial gait variability between freezing episodes; (2) freezing-like episodes of the upper limb occur in PD patients, and tend to be more pronou[...]

Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease    epda.eu.com

Oral administration of this extract significantly reduced dopaminergic cell loss, microgliosis, and accumulation of α-synuclein aggregates. Further, G115 administration fully prevented the developmen[...]

Testing the first portable system for monitoring patients with Parkinson's disease    epda.eu.com

The Technical Research Centre for Dependency Care and Autonomous Living (CETpD) of the Universitat Politècnica de Catalunya has developed a pioneering portable system for monitoring the motor status [...]

Skin may help spot Alzheimer's and Parkinson's disease    epda.eu.com

Scientists have proposed a new idea for detecting brain conditions including Alzheimer's - a skin test. Their work, which is at an early stage, found the same abnormal proteins that accumulate in the[...]

New Parkinson's campaign - Parkure - sets crowdfunding precedent    epda.eu.com

A team of experienced researchers, academics and biotechnologists joined forces under the new University of Edinburgh spin-out Parkure (http://parkure.co.uk) in order to fast-track academic research [...]

UK scientists find new approach to treat Parkinson's disease    epda.eu.com

UK scientists have developed a peptide that sticks to the protein that causes Parkinson's disease, stopping it from killing brain cells. The research highlights a potential new route for slowing the [...]

Michael J. Fox Foundation Analysis Reveals Gaps between Research Volunteers & Parkinson's Clinical Studies    epda.eu.com

A paper authored by The Michael J. Fox Foundation for Parkinson's Research (MJFF) published in the Journal of Parkinson's Disease highlights baseline findings from the first three years of operating [...]

First novel discovery of a physical predictor of freezing in Parkinson's disease    epda.eu.com

MediGait reports a study finding a simple test predicting development of freezing within two years for people with Parkinson's disease.[...]

The Parkinson Alliance Reports Findings Pertaining to Exercise in Parkinson's Disease    epda.eu.com

The Parkinson Alliance (PA) completed their 18th survey based research, entitled Exercise in Parkinson's Disease With and Without DBS: A Closer Look from the Patient's Perspective, to investigate the[...]

Statins may not lower Parkinson's risk    epda.eu.com

The use of statins may not be associated with lowering risk for Parkinson's disease, according to a new study led by researchers at Penn State College of Medicine and National Institute of Environmen[...]

My PD Journey: Urgent action needed to address challenges of Parkinson's disease in Europe with numbers set to double by 2030    epda.eu.com

My PD Journey, an unprecedented multi-stakeholder initiative led by the European Parkinson's Disease Association (EPDA), gathered last week with high-level EU officials and stakeholders from across E[...]

EDF & AGE PLATFORM CALL THE EUROPEAN COMMISSION FOR AN INCLUSIVE DIGITAL SINGLE MARKET STRATEGY    edf-feph.org

This website is supported by the European Union Programme for Employment and Social Solidarity – PROGRESS (2007-2013) One of the highest priorities of the current European Commission is to boost the[...]

Events - Dietary strategies for a healthy ageing - 18 May 2015, Milan, Italy    europa.eu

The proportion of people aged over 65 in Europe is predicted to increase from 25% to 40% by 2030, which is likely to create huge challenges. Research into the types of problem likely to lie ahead inc[...]

The 4th Copenhagen Parkinson Unity Walk    epda.eu.com

The 4th Copenhagen Parkinson Unity Walk on Saturday 30th May 2015, aims to increase public awareness of the illness as well as emphasising the importance of exercise for the wellbeing of people diagn[...]

Rudeness and hostility blight lives of 69,000 with Parkinson's    epda.eu.com

An estimated 69,000 people in the UK with Parkinson's have experienced hostility and rudeness from members of the public according to data released today by Parkinson's UK on the launch of Parkinson'[...]

New growth factor indicates possible regenerative effects in Parkinson's disease    epda.eu.com

Researchers have long sought treatments that can slow the progression of Parkinson's disease. Current treatments have for decades been only symptomatic in nature, supplying the neurotransmitter dopam[...]

New mhealth platform for Parkinson's disease management    epda.eu.com

Funded with 4.4 million Euros by the European Commission the project mHealth platform for Parkinson's Disease management (PD_Manager project), which will allow people with Parkinson to be followed by[...]

Success Stories - Vision of the future: new adaptable lens to prolong sight of aging eyes    europa.eu

As we age our eyes lose their ability to focus quickly on near and far objects. Presbyopia is a common problem that comes with aging, but its causes are not yet fully understood. There is evidence th[...]

Adamas receives Orphan drug designation for ADS-5102 for treatment of levodopa-induced dyskinesia associated with Parkinson's    epda.eu.com

Adamas Pharmaceuticals, Inc. today announced that the Food and Drug Administration (FDA) has granted orphan drug status to ADS-5102 for the treatment of levodopa-induced dyskinesia associated with Pa[...]

International Stem Cell Corporation presents data from Parkinson's disease program at AAN Annual Meeting    epda.eu.com

International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that the company has be[...]

New research reveals how European Governments need to address health information gap to support healthy ageing    epda.eu.com

A new report, published today, by the International Longevity Centre UK (ILC-UK) and supported by an unrestricted grant from Pfizer, explores where consumers go to seek out health information and who[...]

Breath test for Parkinson's disease    epda.eu.com

Experts believe that a simple breath test could help doctors detect and diagnose Parkinson's disease. The test looks for a unique signature of chemicals in exhaled breath.[...]

Creatine Doesn't Slow Parkinson's Progression    epda.eu.com

Despite early promise and a great deal of interest in creatine monohydrate as a possible treatment for Parkinson's disease (PD), a large new double-blind, placebo-controlled trial found that this tre[...]

REMPARK Real-Time Parkinson's Monitoring System    epda.eu.com

Researchers at Polytechnic University of Catalonia, aka BarcelonaTECH, have developed and are testing the new REMPARK (Personal Health Device for the Remote and Autonomous Management of Parkinson's D[...]

Parkinson's disease: Stepping forth into exercise, stepping back into the world    epda.eu.com

From set-dancing to choir sessions, Mags Mullarney's social enterprise Move4Parkinson's is helping people with the degenerative condition to take control of their symptoms.[...]

Great Lakes NeuroTech Pilot Studies Demonstrate Computer Guided Algorithms For Programming Deep Brain Stimulation In Parkinson's    epda.eu.com

Great Lakes NeuroTechnologies announced today they have completed two pilot studies demonstrating computer-guided algorithms for programming deep brain stimulation (DBS) in Parkinson's disease.[...]

Amarantus Announces Publication of Eltoprazine Phase 2a Study for Treating Parkinson's Levodopa-Induced Dyskinesia    epda.eu.com

Amarantus BioSciences Holdings, Inc., a biotechnology company focused on developing diagnostics in neurology, and therapeutic products with the potential for orphan drug designation in the areas of n[...]

Parkinson's Study Dims Ambitions for Gene Flaw Carried by Brin    epda.eu.com

Two of Roche Holding AG's experimental drugs for Parkinson's disease caused lung toxicity in monkeys, researchers said, delivering a setback to one of the most promising pathways to a new type of tre[...]

Diagnosis by keyboard: By revealing loss of motor skills, typing patterns may help to identify early onset of Parkinson's    epda.eu.com

Analysing people's keystrokes as they type on a computer keyboard can reveal a great deal of information about the state of their motor function, according to a new study from Massachusetts Institute[...]

A new tool for understanding Parkinson's disease    epda.eu.com

École Polytechnique Fédérale de Lausanne (EPFL) scientists have developed a new method that can accurately simulate the chemical modification of the protein behind Parkinson's disease. The techniqu[...]

New blood signature analysis may help diagnose Parkinson's disease earlier    epda.eu.com

A new blood test may more accurately identify blood signatures, or biomarkers, for Parkinson's disease (PD), according to a new study published in the journal Movement Disorders.[...]

Neurologists find movement tracking device helps assess severity of Parkinson's disease    epda.eu.com

A device that measures movement and balance can effectively help assess and track the progression of Parkinson's disease, even when medications are used to reduce Parkinson's symptoms, UT Southwester[...]

Blood test aims to detect Parkinson's in early stages    epda.eu.com

Researchers have developed a blood test that they say could help neurologists detect Parkinson's disease and track the illness as it progresses.[...]

Tipping point of Parkinson's Disease, discovered by Cambridge University    epda.eu.com

Scientists believe they have found the tipping point in the brain which triggers Parkinson's Disease in a breakthrough which brings hope of future therapies.[...]

New technologies to help patients with Parkinson's disease    epda.eu.com

The research group of Life Supporting Technologies from Universidad Politécnica de Madrid (UPM) has developed a decision support system for healthcare experts that helps them to manage the informatio[...]

Neutron beams reveal how two potential pieces of Parkinson's puzzle fit    epda.eu.com

To understand diseases like Parkinson's, the tiniest of puzzles may hold big answers. That's why a team including scientists from the National Institute of Standards and Technology (NIST) have determ[...]

Conference 'Innovative Financing Opportunities for Active & Healthy Ageing' (3 June 2015)    europa.eu

European Commission - Brussels, 3 June 2015   About the Conference [...]

Parkinson's Disease Severity and Use of Dopaminergic Medications    epda.eu.com

The outcomes measured at the beginning of the study showed lower disease burden for participants on initial DA monotherapy compared to those taking combined LD and DA therapy after controlling for ag[...]

A pen for people with Parkinson's    epda.eu.com

A brain tumor convinced Lucy Jung to design for those in need. Her arc pen can help patients with Parkinson's disease write legibly.[...]

Low-frequency deep brain stimulation improves difficult-to-treat Parkinson's symptoms    epda.eu.com

Parkinson's disease patients treated with low-frequency deep brain stimulation show significant improvements in swallowing dysfunction and freezing of gait over typical high-frequency treatment.[...]

Can Nerve Stimulators Conquer Parkinson's and Even Obesity?    epda.eu.com

A recent study out of Duke University found that ongoing spinal cord stimulation could improve symptoms of Parkinson's disease. The report also showed that the treatment could safeguard nerve cells f[...]

Vibrating PDShoe May Help Gait in Parkinson's    epda.eu.com

A potential new Parkinson's disease therapy that may help with freezing of gait is being developed at the University of Delaware in collaboration with the All India Institute of Medical Sciences in N[...]

BIAL announces that opicapone significantly improves OFF-time in fluctuating Parkinson's Disease patients as add-on to levodopa    epda.eu.com

BIAL today announced results from a Phase 3, randomized, double-blind, active - and placebo-controlled, parallel group study (BIPARK-I) evaluating opicapone (BIA 9-1067), a novel once-daily catechol-[...]

CHMP Recommends Approval of Xadago™ (Safinamide) to Treat Parkinson´s Disease in the EU    epda.eu.com

First New Chemical Entity (NCE) in 10 years to receive a positive opinion from CHMP for the treatment of Parkinson's disease (PD) patients[...]

New App Helps People with Parkinson's Monitor Their Performance    epda.eu.com

Parkinson's-focused app development company PD Me Tools is pleased to announce the release of a groundbreaking new mobile app that helps people with Parkinson's disease monitor and track their sympto[...]

Wearables & apps for Parkinson's disease: why big data & big names may not be small enough    epda.eu.com

While headlines recently surged over big organisations such as Intel, Apple, and the Michael J. Fox Foundation partnering to launch pilot studies on wearables, mobile apps, and big data for Parkinson[...]

Movement sensor device improves life quality for Parkinson's patients    epda.eu.com

A small sensor, headphones and a mobile phone the elements of a prototype kit that is giving hope of relief for sufferers of Parkinson's disease.[...]

Yumanity Therapeutics Launched to Identify and Develop New Therapies for Neurodegenerative Diseases    epda.eu.com

Company formed to Discover Disease Modifying Therapies for Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis[...]

Newron initiates Phase II study of sNN0031 in patients with Parkinson's disease    epda.eu.com

Newron Pharmaceuticals S.p.A. (Newron), a research and development company focused on novel CNS and pain therapies, announced today the initiation of a Phase II study of its novel molecule sNN0031 in[...]

23andMe and Genentech to Analyze Genomic Data for Parkinson's Disease    epda.eu.com

23andMe, Inc., the leading personal genetics company, today announced an agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to generate whole genome sequencing data f[...]

Impax Pharmaceuticals Announce FDA Approval of RYTARY™ Extended-Release Capsules for the Treatment of Parkinson's disease    epda.eu.com

Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that the U.S. Food and Drug Administration (FDA) approved RYTARY, an extended-release oral capsule formul[...]

Fruit flies used to help cure Parkinson's disease    epda.eu.com

An Edinburgh University spin-out company has been given a massive boost in its efforts to develop a cure for Parkinson's disease using fruit flies.[...]

Sage Bionetworks Launches Parkinson mPower App to Study Parkinson's Disease Symptom Variation    epda.eu.com

Sage Bionetworks a nonprofit biomedical research organization together with collaborators Ray Dorsey MD at the University of Rochester and Max Little PhD at Aston University in the United Kingdom tod[...]

Study establishes connection between gut microbiota and Parkinson's disease    epda.eu.com

Parkinson's disease sufferers have a different microbiota in their intestines than their healthy counterparts, according to a study conducted at the University of Helsinki and the Helsinki University[...]

CUHK study finds depression link to Parkinson's    epda.eu.com

Those who are depressed and cannot sleep may have a higher chance of developing Parkinson's disease and dementia, researchers at Chinese University of Hong Kong believe.[...]

Health-EU Newsletter - Active and Healthy Ageing    europa.eu

During the previous Consumer Electronics Show in Las Vegas, more than half of the new products were related to health. More and more big companies are becoming aware of the worth of our most importa[...]

Risk factors and prodromal markers and the development of Parkinson's disease    epda.eu.com

In this three-center longitudinal, observational study, authors evaluated the specific risk for PD associated with single or combinations of risk factors and prodromal markers. In addition, they eval[...]

European Summit on Innovation for Active and Healthy Ageing, Brussels, 9-10 March 2015    europa.eu

European Commission - Innovation Union - Two day high-level Summit and exhibition organised by the European Commission to discuss how demographic change can offer new opportunities for innovation, gr[...]

Parkinson's disease (PD): EU Commission approves Xadago (safinamide) For mid-late stage PD patients    epda.eu.com

The European Commission approves the use of XADAGO as add-on to L-dopa alone or in combination with other PD medications in mid-late stage PD patients with motor fluctuations[...]

UK scientists find new approach to treat Parkinson's disease    epda.eu.com

UK scientists have developed a peptide that sticks to the protein that causes Parkinson's disease, stopping it from killing brain cells. The research highlights a potential new route for slowing the [...]

Skin may help spot Alzheimer's and Parkinson's disease    epda.eu.com

Scientists have proposed a new idea for detecting brain conditions including Alzheimer's - a skin test. Their work, which is at an early stage, found the same abnormal proteins that accumulate in the[...]

New Parkinson's campaign - Parkure - sets crowdfunding precedent    epda.eu.com

A team of experienced researchers, academics and biotechnologists joined forces under the new University of Edinburgh spin-out Parkure (http://parkure.co.uk) in order to fast-track academic research [...]

Testing the first portable system for monitoring patients with Parkinson's disease    epda.eu.com

The Technical Research Centre for Dependency Care and Autonomous Living (CETpD) of the Universitat Politècnica de Catalunya has developed a pioneering portable system for monitoring the motor status [...]

Michael J. Fox Foundation Analysis Reveals Gaps between Research Volunteers & Parkinson's Clinical Studies    epda.eu.com

A paper authored by The Michael J. Fox Foundation for Parkinson's Research (MJFF) published in the Journal of Parkinson's Disease highlights baseline findings from the first three years of operating [...]

First novel discovery of a physical predictor of freezing in Parkinson's disease    epda.eu.com

MediGait reports a study finding a simple test predicting development of freezing within two years for people with Parkinson's disease.[...]

Statins may not lower Parkinson's risk    epda.eu.com

The use of statins may not be associated with lowering risk for Parkinson's disease, according to a new study led by researchers at Penn State College of Medicine and National Institute of Environmen[...]

The cost-effectiveness of DBS in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson    epda.eu.com

The cost-effectiveness of DBS combined with BMT, versus BMT alone, was evaluated from a UK payer perspective. Individual patient-level data on the effect of DBS on PD symptom progression from a large[...]

Striatal hand in Parkinson's disease: the re-evaluation of an old clinical sign    epda.eu.com

Study findings suggest that in patients without any explanation for hand deformities other than PD, striatal hand occurs very often, and is highly specific for the side of worst PD involvement. We re[...]

New growth factor indicates possible regenerative effects in Parkinson's disease    epda.eu.com

Researchers have long sought treatments that can slow the progression of Parkinson's disease. Current treatments have for decades been only symptomatic in nature, supplying the neurotransmitter dopam[...]

New mhealth platform for Parkinson's disease management    epda.eu.com

Funded with 4.4 million Euros by the European Commission the project mHealth platform for Parkinson's Disease management (PD_Manager project), which will allow people with Parkinson to be followed by[...]

New research reveals how European Governments need to address health information gap to support healthy ageing    epda.eu.com

A new report, published today, by the International Longevity Centre UK (ILC-UK) and supported by an unrestricted grant from Pfizer, explores where consumers go to seek out health information and who[...]

Creatine Doesn't Slow Parkinson's Progression    epda.eu.com

Despite early promise and a great deal of interest in creatine monohydrate as a possible treatment for Parkinson's disease (PD), a large new double-blind, placebo-controlled trial found that this tre[...]

Breath test for Parkinson's disease    epda.eu.com

Experts believe that a simple breath test could help doctors detect and diagnose Parkinson's disease. The test looks for a unique signature of chemicals in exhaled breath.[...]

Amarantus Announces Publication of Eltoprazine Phase 2a Study for Treating Parkinson's Levodopa-Induced Dyskinesia    epda.eu.com

Amarantus BioSciences Holdings, Inc., a biotechnology company focused on developing diagnostics in neurology, and therapeutic products with the potential for orphan drug designation in the areas of n[...]

GLNT Secures Allowance Of Patent For Controlling Parkinson's Therapy In Response To Symptoms    epda.eu.com

Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office. The application covers a system and method of controlling Parkinson's therapy[...]

Great Lakes NeuroTech Pilot Studies Demonstrate Computer Guided Algorithms For Programming Deep Brain Stimulation In Parkinson's    epda.eu.com

Great Lakes NeuroTechnologies announced today they have completed two pilot studies demonstrating computer-guided algorithms for programming deep brain stimulation (DBS) in Parkinson's disease.[...]

Events - European Summit on Innovation for Active and Healthy Ageing - 9-10 March 2015, Brussels, Belgium    europa.eu

The Summit on Innovation for Active and Healthy Ageing aims to engage Europe's policy, services and market leaders to co-create a shared vision on how Europe can address the challenges and seize the [...]

Parkinson's Study Dims Ambitions for Gene Flaw Carried by Brin    epda.eu.com

Two of Roche Holding AG's experimental drugs for Parkinson's disease caused lung toxicity in monkeys, researchers said, delivering a setback to one of the most promising pathways to a new type of tre[...]

Parkinson's Vaccine: EU-Team Launches Clinical Trial    epda.eu.com

A novel Parkinson's vaccine will now be tested in a clinical Phase I trial in Austria by an EU-funded consortium. The vaccine was developed by the Austrian biotech company AFFiRiS AG and targets a pr[...]

ACADIA Pharmaceuticals Presents Caregiver Burden Data at the International Congress of Non-Motor Dysfunctions in Parkinson's Dis    epda.eu.com

Data from an analysis of Phase III studies in patients with PDP showed that treatment with NUPLAZID reduced caregiver burden compared to PDP patients on placebo.[...]

Apathy in untreated early-stage Parkinson disease: Relationship with other non-motor symptoms    epda.eu.com

Apathetic patients had significantly more severe motor symptoms (P < 0.001) and a lower cognitive status (P = 0.032) than non-apathetic patients. When considering non-motor symptoms, apathy was si[...]

Conversion between Mini-Mental State Examination, Montreal Cognitive Assessment & Dementia Rating Scale-2 scores in Parkinson's    epda.eu.com

The primary aim of this study was to apply a simple and reliable algorithm for the conversion of MoCA to MMSE scores in PD patients. A secondary aim was to apply this algorithm for the conversion of [...]

Stem cells from adult nose tissue used to cure Parkinson's disease in rats    epda.eu.com

Scientists have for the first time used adult human stem cells to cure rats with Parkinson's disease, a neurodegenerative illness that currently has no cure.[...]

Blood test aims to detect Parkinson's in early stages    epda.eu.com

Researchers have developed a blood test that they say could help neurologists detect Parkinson's disease and track the illness as it progresses.[...]

Neurologists find movement tracking device helps assess severity of Parkinson's disease    epda.eu.com

A device that measures movement and balance can effectively help assess and track the progression of Parkinson's disease, even when medications are used to reduce Parkinson's symptoms, UT Southwester[...]

Tipping point of Parkinson's Disease, discovered by Cambridge University    epda.eu.com

Scientists believe they have found the tipping point in the brain which triggers Parkinson's Disease in a breakthrough which brings hope of future therapies.[...]

Neutron beams reveal how two potential pieces of Parkinson's puzzle fit    epda.eu.com

To understand diseases like Parkinson's, the tiniest of puzzles may hold big answers. That's why a team including scientists from the National Institute of Standards and Technology (NIST) have determ[...]

New technologies to help patients with Parkinson's disease    epda.eu.com

The research group of Life Supporting Technologies from Universidad Politécnica de Madrid (UPM) has developed a decision support system for healthcare experts that helps them to manage the informatio[...]

Disorders of the Oral Cavity in Parkinson's Disease and Parkinsonian Syndromes    epda.eu.com

This paper reviews current knowledge regarding the epidemiology, pathophysiology, and treatment options of disorders of the oral cavity in Parkinson's disease patients.[...]

Structural MRI correlates of the MMSE and pentagon copying test in Parkinson's disease    epda.eu.com

Study results suggest MMSE and the pentagon item reflect brain changes which at a regional level involve mainly posterior regions. Correlates of the pentagon item were seen in the same regions where [...]

Peripheral nervous system involvement in Parkinson's disease: evidence and controversies    epda.eu.com

In this review, authors discuss the different hypotheses, as well as our perspective on open issues and controversies.[...]

Dyskinesias and motor symptoms onset in Parkinson disease    epda.eu.com

Conclusions: The partial association between the body site of motor symptoms and of LID onset likely reflects pathophysiological mechanisms underlying LID.[...]

Sensitive measures of executive dysfunction in non-demented Parkinson's disease    epda.eu.com

No significant differences between groups were observed on widely used clinical measures. The PD patients scored lower than controls on the EXAMINER Executive Composite, Cognitive Control, and Workin[...]

Rotigotine vs ropinirole in advanced stage Parkinson's disease: A double-blind study    epda.eu.com

Conclusions: Rotigotine was well tolerated at doses up to 16 mg/24 h and showed similar efficacy to ropinirole except that the application site reaction was much higher in the rotigotine group.[...]

Swallowing disturbances in Parkinson's disease: A multivariate analysis of contributing factors    epda.eu.com

Conclusions: Gender, age, disease duration and dementia all seem to contribute to the occurrence of swallowing disturbances independently. However, the role played by these factors in sub-groups of p[...]

New App Helps People with Parkinson's Monitor Their Performance    epda.eu.com

Parkinson's-focused app development company PD Me Tools is pleased to announce the release of a groundbreaking new mobile app that helps people with Parkinson's disease monitor and track their sympto[...]

Disclaimer

The European Commission is solely responsible for information present on EU-level websites, information present in the Portal originated by the Commission. National-level information is provided by the Member States concerned and Member States are solely responsible for the accuracy of the information. Likewise, the European Commission is not responsible for information on non-governmental organisations and international organisations websites. The European Union is committed to user privacy. Read more concerning the Legal Notice.
Further questions can be answered through the Contact page. The Health-EU portal supports principles and measures to increase the credibility of information on the net. It complies with the HONcode standard for trustworthy health information: verify here.